Good Manufacturing Practice is often described as common sense written down. That is true — but the sites that sail through inspections and the sites that struggle are separated by how rigorously that common sense is implemented, evidenced and sustained. This article walks through the GMP fundamentals that inspectors actually probe, and where most findings originate.
Quality starts with the system, not the paperwork
A Pharmaceutical Quality System aligned to ICH Q10 is the backbone of GMP compliance. Inspectors do not just want to see that you have procedures — they want evidence that your deviation, CAPA, change-control, risk-management and management-review processes connect and reinforce one another.
The most common structural weakness we see is a quality system that exists on paper but operates in silos: deviations that never feed risk assessments, CAPAs that close without effectiveness checks, and management reviews that rubber-stamp metrics nobody acts on. A healthy system is connected — a signal in one process triggers action in another.
Data integrity is now the dominant theme
For the better part of a decade, data integrity has driven the most serious regulatory actions. ALCOA+ — that records be Attributable, Legible, Contemporaneous, Original and Accurate, plus Complete, Consistent, Enduring and Available — is the lens every inspector applies.
The vulnerabilities are predictable:
- Audit trails that exist but are never reviewed, or are configured so they can be disabled.
- Shared logins and excessive privileges that break attributability and segregation of duties.
- "Testing into compliance" — re-running analyses until a passing result appears, without controlling the original data.
Closing these gaps is partly technical (system configuration, access control) and partly cultural. Inspectors read behavior as much as records: how staff talk about re-testing, how quickly they retrieve original data, and whether review is a genuine check or a signature.
Investigations that reach root cause
Weak investigations are a leading indicator of a struggling site. A deviation closed with "operator error — retrained" and no deeper analysis tells an inspector that the real cause is unknown and the problem will recur.
Strong CAPA systems share three traits:
- Structured root-cause analysis appropriate to the problem — 5-Whys for simple issues, fishbone or fault-tree for complex ones.
- Corrective actions that address the system, not just the instance — fixing the procedure or control, not only the affected batch.
- Effectiveness checks that demonstrate, with evidence, that the action worked and the deviation has not recurred.
The presence of effectiveness checks is one of the clearest signals of CAPA maturity, and one of the first things a skilled inspector looks for.
Validation as a lifecycle, not an event
Modern expectations treat process validation as a three-stage lifecycle: process design, process qualification, and continued process verification. Sites that still rely on a one-time validation exercise — with no ongoing monitoring of critical parameters — are increasingly exposed.
Continued Process Verification is the stage most often missing. A robust CPV program with the right parameters, sampling and statistical trending demonstrates that your process stays in a state of control between formal revalidations.
Inspection readiness is a discipline, not a scramble
Finally, the difference between a calm inspection and a chaotic one is preparation. Document readiness, rehearsed front-room/back-room processes, and subject-matter experts who can answer precisely — without over-disclosing — turn an inspection from an interrogation into a controlled conversation.
A mock inspection four to eight weeks before the real event is one of the highest-return investments a site can make: it surfaces gaps while there is still time to remediate, and rehearses the human factors that genuinely move inspection outcomes.
The takeaway
GMP compliance is not about thicker binders. It is about a connected quality system, trustworthy data, investigations that reach root cause, validation that lives as a lifecycle, and a team that is genuinely ready. Get those fundamentals right, and inspections become a confirmation of what you already know — not a source of surprises.
PharmExpert conducts independent GMP audits, mock inspections and remediation programs worldwide. Talk to a specialist about preparing your site.